Condensed Statements of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Beginning balances at Jan. 31, 2014	$ (233,915)	$ 1,900	$ 8,418,684	$ (8,529,007)	$ (125,492)
Shares, Beginning balance at Jan. 31, 2014		1,899,575
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net loss	(58,564)	0	0	0	(58,564)
Ending balances at Oct. 31, 2014	$ (292,479)	$ 1,900	$ 8,418,684	$ (8,529,007)	$ (184,056)
Shares, Ending balance at Oct. 31, 2014		1,899,575